
Apeximmune
Developer of novel biologics designed to modulate the immune system. The company's platform combines bioinformatics with biological assays to enable the identification of novel immune-modulating targe...
Valuation
$62.7M
Latest known
Share Price
N/A
Total Raised
$32.8M
Last Round
N/A